medic suppli devic
reason report
quick actual solid quarter optic look less
bottom line morn deliv sale
y/i report oper ep
report ahead us consensu
encouragingli consecut sale beat follow
misstep strength offset under-perform
medic deliveri clinic nutrit busi optic
around medic deliveri growth vs consensu well
driver ep out-performance result rais may
muddi water bit actual think strong quarter
increas investor confid diversifi portfolio
abil manag business-specif headwind
continu drive posit leverag specif point
follow give us increas confid reiter
medic deliveri sale growth guidanc could suggest
perhap -- street -- mis-model vs toughest y/
compar includ posit impact tie
substanti buy-in iv therapi clearli manag feel
busi perform expect quarter though acknowledg
investor may still comfort around achiev
guidanc base perform far tell
pharmaceut out-performance necessarili benefit one-
time item higher-than-expect cyclo brevibloc sale
rather strength across core portfolio sustain
natur wait manag provid clariti call
manag guid brevibloc headwind
even ex lower tax share count impact deliv
ep out-performance pure better oper perform
 better sale oper margin
howev note medic deliveri came
declin report y/i oper miss
estim miss consensu
clinic nutrit also came street ep
perspect also estim beat driven lower
tax share count investor may less inclin give
credit -- mayb importantli rais ep guid
midpoint vs beat vs guidanc
confer call estimate dial-in passcod
revenu ep vs
street estim total sale came
us street pharmaceut drove
major out-performance quarter offset under-perform
vs us consensu medic deliveri clinic nutrit
medic deliveri came declin report
y/i oper albeit though comp miss estim
miss consensu clinic nutrit also came
us street
pleas refer page import disclosur price chart analyst certif
miss might attribut mis-model street think
rais question post-earn call whether two
segment -- combin make total sale -- track
restor growth year progress investor would tri get
comfort sale guidanc oper growth
medic deliveri oper clinic nutrit
believ quarter prove least off-set weak
elsewher given manag reiter sale guidanc
oper growth oper sale growth adjust
cyclophosphamid competit clari strateg product/market
exit came declin vs
flat vs y/
y/i y/i oper margin
came bp ahead us bp ahead
rais ep reiter
sale guidanc constant currenc basi
oper guid ep vs us
street sale growth oper
constant currenc basi declin report
basi vs current oper growth project declin
y/i report
question call market dynam
medic deliveri clinic nutrit chang meaning
give confid abil drive acceler sale
growth busi fast-grow cash balanc
intensifi focu portfolio manag
appetit -- potenti size time type asset
increment portfolio reshap activ like order
add higher growth higher margin busi also shed lower
growth lower margin busi key pipelin initi
drive acceler sale growth next year
increment lever pull drive continu margin
expans beyond
dollar million except per share data
good sold
research develop expens
pre-tax incom continu
revenu
consensu incom statement item includ contributor factset
consensu detail revenu item visibl alpha
baxter sale y/i
sale billion usd
